2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 11.115 | 46.620 | 53.227 | - | - | 28.355 | 19.123 | 41.590 | 36.193 | 88.696 |
Total Income - EUR | 11.115 | 46.620 | 53.227 | - | - | 28.355 | 19.123 | 41.590 | 36.193 | 106.214 |
Total Expenses - EUR | 6.078 | 15.692 | 22.802 | - | - | 26.357 | 21.140 | 16.054 | 36.460 | 55.570 |
Gross Profit/Loss - EUR | 5.037 | 30.928 | 30.425 | - | - | 1.998 | -2.016 | 25.535 | -267 | 50.645 |
Net Profit/Loss - EUR | 4.551 | 29.530 | 29.360 | - | - | 1.131 | -2.208 | 25.164 | -597 | 49.804 |
Employees | 0 | 1 | 1 | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anelin Med Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 122 | 123 | 23.322 | - | - | 9.323 | 9.729 | 5.437 | 1.365 | 49.779 |
Current Assets | 5.194 | 41.572 | 66.678 | - | - | 143.207 | 226.526 | 247.521 | 128.930 | 150.723 |
Inventories | 8 | 9 | 8 | - | - | 0 | 0 | 0 | 0 | 901 |
Receivables | 0 | 13.677 | 10.657 | - | - | 15.751 | 104.206 | 106.139 | 106.463 | 109.175 |
Cash | 5.185 | 27.886 | 56.013 | - | - | 127.455 | 122.320 | 141.382 | 22.467 | 40.647 |
Shareholders Funds | 4.596 | 34.164 | 63.176 | - | - | 137.474 | 132.660 | 154.882 | 33.099 | 77.749 |
Social Capital | 45 | 45 | 45 | - | - | 42 | 41 | 40 | 41 | 40 |
Debts | 720 | 7.531 | 26.825 | - | - | 15.055 | 103.595 | 98.076 | 97.196 | 122.754 |
Income in Advance | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Anelin Med Srl